News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

What's On 'KLH?

Hire Me MKE

HireMeMKE_620x400

Looking for a job around the Milwaukee area? Check out some openings>>

Wanna Play DJ?

HEYMOM

You can host your own show Sunday night at 6 on ‘KLH!

Recent Headlines

in Sports

This week’s top sports shots

AP633953798161

A look at the biggest stories and best photography in sports this week.

in National

Making headlines this week

sunflower

A look at the week's biggest newsmakers and the stories you won't soon forget.

in Sports

This weekend’s sports schedule

cowboys

A complete look at this weekend's sports schedule.